Honeysuckle liquid medicine for treating gynecologic inflammation

A technology of gynecological inflammation and honeysuckle, which is applied in the direction of anti-infective drugs, drug combinations, and pharmaceutical formulas, and can solve problems such as difficult control, dependence, and easy recurrence

Inactive Publication Date: 2007-10-31
王军
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Although existing western medicine has therapeutic effect, its side effect is big, has dependence, recurs easily, is difficult to control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] Honeysuckle medicinal liquid for gynecological inflammation is composed of the following formula ratio: 35 grams of honeysuckle, 30 grams of Sophora flavescens, 5 grams of Baibu and Cnidium, 10 grams each of pepper eye and raw licorice, decocted in water.

Embodiment 2

[0011] The liquid honeysuckle for gynecological inflammation is composed of the following formula ratio: 35 grams of honeysuckle, 30 grams of Sophora flavescens, 5 grams of Baibu and Cnidium, 10 grams each of Jiaomu and raw licorice, 12 grams each of Zhicangshu and Angelica dahurica, decocted in water Take the liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese medicinal decoction for treating trichomonal vaginitis, which is prepared from the following constituents: honeysuckle flower 35g, flavescent sophora root 30g, roor of sessile stemona, cnidium fruit each 5g, zanthoxylum piperitum, licorice root each 10g.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicinal liquids, in particular to medicinal liquids for treating trichomonal vaginitis. Background technique [0002] Though existing western medicine has therapeutic effect, its side effect is big, has dependence, relapse easily, and is difficult to control. Contents of the invention [0003] The purpose of the present invention is to provide women with a medicinal solution that has no side effects and no recurrence in treatment. [0004] The technical scheme provided for realizing the purpose of the present invention is: 35 grams of honeysuckle, 30 grams of Sophora flavescens, 5 grams of Aphrodisiac, Cnidium, each 10 grams of pepper order, raw licorice, decocted in water to get the liquid, used to wash the vagina, 10-15 minutes each time. [0005] The beneficial effects of the invention are: convenient manufacture, easy-to-obtain materials, low price, and obvious effect on trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/904A61P15/02A61P33/02
Inventor 王军
Owner 王军
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap